SP1 and cancer: While the emCpGs harbour enriched binding sites for their specific emTFs, the non-correlated CpGs shared a binding signatures for SP1, CTCF, NRF1, GABPA, KLF9, and YY1 providing a protective effect against de novo methylation across cancer types.